Mercado de farmacovigilancia: mapeo competitivo y perspectivas estratégicas 2031

  • Report Code : TIPRE00003127
  • Category : Life Sciences
  • No. of Pages : 150
Buy Now

Pharmacovigilance Market SWOT Analysis by 2031

Buy Now

La farmacovigilancia (FV) se define como la ciencia y las actividades relacionadas con la detección, evaluación, comprensión y prevención de efectos adversos o cualquier otro problema relacionado con los medicamentos. La farmacovigilancia desempeña un papel importante en los sectores farmacéutico y biotecnológico en el diseño de medicamentos y sus interacciones. La farmacovigilancia implica recopilar información de los proveedores de atención médica y de los pacientes para conocer los peligros asociados con los medicamentos.

Se espera que el aumento de los casos de reacciones adversas a los medicamentos y el aumento del consumo de medicamentos en todo el mundo impulsen el crecimiento de la farmacovigilancia. mercado durante el período de pronóstico. Además, se prevé que el cambio en la subcontratación de diversas actividades entre el sector farmacéutico y de ciencias biológicas ofrezca importantes oportunidades de crecimiento en el mercado.

El "Análisis del mercado global de farmacovigilancia hasta 2031" es un estudio especializado y en profundidad. de la industria de TI para el cuidado de la salud con un enfoque en la tendencia del mercado global. El informe tiene como objetivo proporcionar una visión general del mercado global con una segmentación detallada del mercado por fase de ensayo clínico, proveedor de servicios, tipo de método, usuario final y geografía. Se espera que el mercado global sea testigo de un alto crecimiento durante el período previsto. El informe proporciona estadísticas clave sobre el estado del mercado de los principales actores del mercado de farmacovigilancia y ofrece tendencias y oportunidades clave en el mercado.

El mercado mundial de farmacovigilancia está segmentado según la fase de ensayo clínico, el proveedor de servicios, tipo de método y usuario final. Según la fase del ensayo clínico, el mercado se clasifica como Preclínico, Fase I, Fase II, Fase III y Fase IV. De manera similar, según el tipo de servicio, el mercado se clasifica en subcontratación interna y por contrato. El mercado de farmacovigilancia está segmentado según el tipo de método, como informes espontáneos, informes de ADR intensificados, informes espontáneos dirigidos, seguimiento de eventos de cohortes y extracción de EHR. Según el usuario final, el mercado se clasifica en hospitales, organizaciones de investigación e industriales.

El informe proporciona una descripción detallada de la industria que incluye información tanto cualitativa como cuantitativa. Proporciona una descripción general y una previsión de la fase de ensayo clínico basada en el mercado mundial de farmacovigilancia, el proveedor de servicios, el tipo de método y el usuario final. También proporciona el tamaño del mercado y el pronóstico hasta 2031 para el mercado general con respecto a cinco regiones principales, a saber; América del Norte, Europa, Asia-Pacífico (APAC), Medio Oriente y África (MEA) y Sur y África. Centroamérica. El mercado de farmacovigilancia de cada región se subsegmenta posteriormente en los respectivos países y segmentos. El informe cubre el análisis y el pronóstico de 18 países a nivel mundial junto con las tendencias actuales y las oportunidades que prevalecen en la región.
Se espera que América del Norte contribuya a la mayor participación en el mercado de farmacovigilancia en los próximos años, debido a la presencia de los principales actores del mercado en la región junto con las iniciativas para reducir el gasto en atención médica, así como una infraestructura de atención médica sofisticada. Se prevé que Asia Pacífico sea testigo de un crecimiento significativo en el mercado durante el período de pronóstico, debido a la creciente adopción de TI en el campo de la atención médica para ofrecer mejores servicios a los pacientes.

El informe analiza los factores que afectan el mercado de la farmacovigilancia. tanto desde el lado de la demanda como de la oferta y evalúa más a fondo la dinámica del mercado que afecta al mercado durante el período de pronóstico, es decir, impulsores, restricciones, oportunidades y tendencias futuras. El informe también proporciona un análisis PEST exhaustivo para las cinco regiones, a saber; América del Norte, Europa, APAC, MEA y Sur y Sur. Centroamérica después de evaluar los factores políticos, económicos, sociales y tecnológicos que afectan el mercado de Farmacovigilancia en estas regiones.

El informe también incluye los perfiles de empresas clave de farmacovigilancia junto con sus análisis FODA y estrategias de mercado. Además, el informe se centra en los principales actores de la industria con información como perfiles de empresas, componentes y servicios ofrecidos, información financiera de los últimos 3 años y desarrollos clave en los últimos cinco años. Algunos de los actores clave que operan en el mercado de farmacovigilancia incluyen Accenture, Bristol-Myers Squibb Company, Linical Accelovance, Cognizant, Covance Inc., F. Hoffmann-La Roche Ltd., GlaxoSmithKline plc., ICON plc, Capgemini (IGATE Corporation) y Novartis AG, entre otros.
Report Coverage
Report Coverage

Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

Segment Covered
Segment Covered

This text is related
to segments covered.

Regional Scope
Regional Scope

North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

Country Scope
Country Scope

This text is related
to country scope.

The List of Companies

1. Accenture
2. Bristol-Myers Squibb Company
3. Linical Accelovance
4. Cognizant
5. Covance Inc.
6. F. Hoffmann-La Roche Ltd.
7. GlaxoSmithKline plc.
8. ICON plc
9. Capgemini (IGATE Corporation)
10. Novartis AG

The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.

  1. Data Collection and Secondary Research:

As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.

Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.

  1. Primary Research:

The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.

For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.

A typical research interview fulfils the following functions:

  • Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
  • Validates and strengthens in-house secondary research findings
  • Develops the analysis team’s expertise and market understanding

Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:

  • Industry participants: VPs, business development managers, market intelligence managers and national sales managers
  • Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.

Below is the breakup of our primary respondents by company, designation, and region:

Research Methodology

Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.

  1. Data Analysis:

Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.

  • Macro-Economic Factor Analysis:

We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.

  • Country Level Data:

Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.

  • Company Profile:

The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.

  • Developing Base Number:

Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.

  1. Data Triangulation and Final Review:

The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.

We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.

We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.

Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Trends and growth analysis reports related to Life Sciences : READ MORE..